
Peter L. Lakatos
Üllői St. 26
Budapest, BU 1085, Hungary
Budapest, BU 1085, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 322 publications
Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis.
Journal: Journal of Crohn's & colitis
Published: May 20, 2026
IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?
Journal: Journal of clinical medicine
Published: May 13, 2026
Evaluation of Long-Term Outcomes of Crohn's Disease Complicated by Intra-Abdominal Abscess: A Retrospective International Cohort Study.
Journal: Journal of clinical medicine
Published: February 17, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled Analysis.
Journal: Alimentary pharmacology & therapeutics
Published: January 05, 2026
Clinical Value of Anti-Integrin αvβ6 Antibody Serum-Level Measurement in Inflammatory Bowel Diseases.
Journal: Journal of clinical medicine
Published: December 19, 2025
A 3D Alginate-Gelatin Co-Culture Model to Study Epithelial-Stromal Interactions in the Gut.
Journal: Gels (Basel, Switzerland)
Published: December 18, 2025
Successful Treatment of Refractory Pruritus in Primary Sclerosing Cholangitis with Upadacitinib: A Case Report.
Journal: Case reports in gastroenterology
Published: October 29, 2025
Extensive Colonic Pseudopolyposis Leading to Protein-Losing Enteropathy and Severe Hypoalbuminemia With Refractory Ulcerative Colitis.
Journal: ACG case reports journal
Published: October 09, 2025
Do we need to treat dialysis patients differently? Infliximab therapy in a patient with ulcerative colitis on hemodialysis: a case report.
Journal: Journal of medical case reports
Published: September 29, 2025
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.
Journal: Journal of Crohn's & colitis
Published: September 19, 2025
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: September 17, 2025
Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management.
Journal: Expert opinion on biological therapy
Published: September 05, 2025
Last Updated: 09/26/2026